Starbucks (SBUX) is catching Wall Street's attention as it prepares to release its second-quarter earnings report on Tuesday. Analysts expect the coffee...
) is catching Wall Street's attention as it prepares to release its second-quarter earnings report on Tuesday. Analysts expect the coffee chain to report weaker same store sales and a decrease in foot traffic .analyzes the disappointing earnings investors are bracing for, examining new menu items Starbucks has introduced in an effort to boost sales.The coffee giant expected to report declining same store sales growth as investors remain cautious on the coffee chain.
Investors are also eager to hear how that pairing menu performed that was somewhat of a value meal that Starbucks introduced far off from what the, uh, coffee chain typically does that offered a small iced or hot coffee with a butter croissant or breakfast sandwich for $5 or $6. Bank of America analyst Sarah San to saying in a note earlier earlier this week that Starbucks performance in China is tied to industry wide struggles.We did hear from McDonald's today.
MIAMI, July 29, 2024--Pulse Biosciences, Inc. , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ technology, today announced it will report financial results for the second quarter 2024 after market close on Monday, August 12, 2024. Company management will host a corresponding conference call beginning at 1:30pm PT / 4:30pm ET.HOUSTON, July 29, 2024--SilverBow Resources, Inc.
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Starbucks rises after Elliott Management takes stake: WSJStarbucks (SBUX) stock receives late-day gains Friday after the Wall Street Journal reported activist investor Elliott Management has taken a stake in the...
Read more »
Why the tech stock selloff isn't over yet: Wall Street strategistsTop strategists warn the tech selloff is far from over amid worry over slowing earnings growth.
Read more »
Why Wall Street is unfazed by Medicare drug pricing threatMedicare drug pricing negotiations are done and Wall Street is getting a good signal from drug CEOs.
Read more »
Top Wall Street strategist explains why he's abandoning an S&P 500 targetPiper Sandler will no longer release year-end price targets for the S&P 500 after concluding that the index no longer truly reflects the stock market's...
Read more »
Why Wall Street is still worried about regional banksThe stock of Dallas regional bank First Foundation plummeted following a $228 million infusion, the latest reminder that commercial real estate challenges...
Read more »
This improvement could win back Starbucks customers: AnalystStarbucks (SBUX) has struggled in its recent earnings as high-priced menu items turn consumers away. AB Bernstein senior analyst Danilo Gargiulo joins the...
Read more »